FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242984201> ?p ?o ?g. }

• W4242984201 endingPage "20" @default.
• W4242984201 startingPage "17" @default.
• W4242984201 abstract "International Journal of Endocrine OncologyVol. 1, No. 1 Ask the ExpertBronchial carcinoidsDan GranbergDan GranbergSearch for more papers by this authorPublished Online:15 Sep 2014https://doi.org/10.2217/ije.14.12AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReferences1 Travis WD, Colby TV, Corrin B et al.. World Health Organization: Histological Typing of Lung and Pleural Tumours (3rd Edition). Springer, Berlin, Germany (1999).Crossref, Google Scholar2 Bertelsen S, Aasted A, Lund C et al. Bronchial carcinoid tumors – a clinicopathologic study of 82 cases. Scand. J. Thor. Cardiovasc. Surg. 19, 105–111 (1985)Crossref, Medline, CAS, Google Scholar3 McCaughan BC, Martini N, Bains MS. Bronchial carcinoids – review of 124 cases. J. Thorac. Cardiovasc. Surg. 89, 8–17 (1985)Crossref, Medline, CAS, Google Scholar4 Granberg D, Sundin A, Janson ET et al. Octreoscan in patients with bronchial carcinoid tumours. Clin. Endocrinol. 59, 793–799 (2003)Crossref, Medline, Google Scholar5 Örlefors H, Sundin A, Garske U et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors – comparison with somatostatin receptor scintigraphy and computed tomography. J. Clin. Endocrinol. Metab. 90, 3392–400 (2005)Crossref, Medline, CAS, Google Scholar6 Neyman K, Sundset A, Naalsund A et al. Endoscopic treatment of bronchial carcinoids in comparison to surgical resection: a retrospective study. J. Bronchology Interv. Pulmonol. 19, 29–34 (2012)Crossref, Medline, Google Scholar7 Brokx HA, Risse EK, Paul MA et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J. Thorac. Cardiovasc. Surg. 133, 973–978 (2007)Crossref, Medline, Google Scholar8 Rindi G, Klöppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 449, 395–401 (2006)Crossref, Medline, CAS, Google Scholar9 Ekeblad S, Sundin A, Tiensuu Janson E et al. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin. Cancer Res. 13, 2986–2991 (2007)Crossref, Medline, CAS, Google Scholar10 Crona J, Fanola I, Lindholm DP et al. Effect of temozolomide in patients with metastatic bronchial carcinoids. Neuroendocrinology 98, 151–155 (2013)Crossref, Medline, CAS, Google Scholar11 Imhof A, Brunner P, Marincek N et al. Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. J. Clin. Oncol. 29, 2416–2423 (2011)Crossref, Medline, CAS, Google Scholar12 van Essen M, Krenning EP, Bakker WH et al. Peptide receptor radionuclide therapy with (177)Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin. Eur. J. Nucl. Med. Mol. Imaging 34, 1219–1227 (2007)Crossref, Medline, CAS, Google Scholar13 Fazio N, Granberg D, Grossman A et al. Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the Phase 3, randomized, placebo-controlled RADIANT-2 study. Chest 143, 955–962 (2013)Crossref, Medline, CAS, Google Scholar14 Larsson DE, Hassan S, Larsson R et al. Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines. Cancer Chemother. Pharmacol. 65, 5–12 (2009)Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 1, No. 1 Follow us on social media for the latest updates Metrics Downloaded 98 times History Published online 15 September 2014 Published in print August 2014 Information© Future Medicine LtdDisclaimerThe opinions expressed in this article are those of the interviewee and do not necessarily reflect the views of Future Medicine Ltd.Financial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W4242984201 created "2022-05-12" @default.
• W4242984201 creator A5022827045 @default.
• W4242984201 date "2014-08-01" @default.
• W4242984201 modified "2023-10-18" @default.
• W4242984201 title "Bronchial carcinoids" @default.
• W4242984201 cites W1514053247 @default.
• W4242984201 cites W1578849454 @default.
• W4242984201 cites W2000741337 @default.
• W4242984201 cites W2009629472 @default.
• W4242984201 cites W2011916383 @default.
• W4242984201 cites W2015286231 @default.
• W4242984201 cites W2015359861 @default.
• W4242984201 cites W2019911597 @default.
• W4242984201 cites W2052937921 @default.
• W4242984201 cites W2063178653 @default.
• W4242984201 cites W2118672029 @default.
• W4242984201 cites W2138614007 @default.
• W4242984201 cites W2142340968 @default.
• W4242984201 cites W2224258443 @default.
• W4242984201 doi "https://doi.org/10.2217/ije.14.12" @default.
• W4242984201 hasPublicationYear "2014" @default.
• W4242984201 type Work @default.
• W4242984201 citedByCount "0" @default.
• W4242984201 crossrefType "journal-article" @default.
• W4242984201 hasAuthorship W4242984201A5022827045 @default.
• W4242984201 hasConcept C142724271 @default.
• W4242984201 hasConcept C17744445 @default.
• W4242984201 hasConcept C199539241 @default.
• W4242984201 hasConcept C2779066768 @default.
• W4242984201 hasConcept C2779473830 @default.
• W4242984201 hasConcept C2989005 @default.
• W4242984201 hasConcept C61434518 @default.
• W4242984201 hasConcept C71924100 @default.
• W4242984201 hasConceptScore W4242984201C142724271 @default.
• W4242984201 hasConceptScore W4242984201C17744445 @default.
• W4242984201 hasConceptScore W4242984201C199539241 @default.
• W4242984201 hasConceptScore W4242984201C2779066768 @default.
• W4242984201 hasConceptScore W4242984201C2779473830 @default.
• W4242984201 hasConceptScore W4242984201C2989005 @default.
• W4242984201 hasConceptScore W4242984201C61434518 @default.
• W4242984201 hasConceptScore W4242984201C71924100 @default.
• W4242984201 hasIssue "1" @default.
• W4242984201 hasLocation W42429842011 @default.
• W4242984201 hasOpenAccess W4242984201 @default.
• W4242984201 hasPrimaryLocation W42429842011 @default.
• W4242984201 hasRelatedWork W2019250753 @default.
• W4242984201 hasRelatedWork W2071494235 @default.
• W4242984201 hasRelatedWork W2102644969 @default.
• W4242984201 hasRelatedWork W2292407264 @default.
• W4242984201 hasRelatedWork W2766770000 @default.
• W4242984201 hasRelatedWork W2770144974 @default.
• W4242984201 hasRelatedWork W2967287585 @default.
• W4242984201 hasRelatedWork W3208701539 @default.
• W4242984201 hasRelatedWork W4313346385 @default.
• W4242984201 hasRelatedWork W4317816533 @default.
• W4242984201 hasVolume "1" @default.
• W4242984201 isParatext "false" @default.
• W4242984201 isRetracted "false" @default.
• W4242984201 workType "article" @default.